Biotech News
Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
ir.tangotx.com2026-05-06 15:29 EST
BOSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Malte Peters, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on